Kura Oncology publishes ziftomenib combination study in Blood journal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. FUL
7. LAES
8. USO
9. NNE
10. IONS

Go back to Kura Oncology publishes ziftomenib combination study in Blood journal
(NASDAQ: KURA) Delayed: 10.79 +0.17 (1.60%)
Previous Close $10.62    52 Week High $8.90 
Open $10.63    52 Week Low $2.50 
Day High $10.90    P/E N/A 
Day Low $10.44    EPS $0.00 
Volume 479,535